628 related articles for article (PubMed ID: 17309182)
1. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
2. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
3. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
[TBL] [Abstract][Full Text] [Related]
4. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
Altintas A; Cil T; Pasa S; Danis R; Kilinc I; Ayyildiz O; Muftuoglu E
Minerva Med; 2008 Feb; 99(1):7-14. PubMed ID: 18299692
[TBL] [Abstract][Full Text] [Related]
6. Multiplex assessment of non-organ-specific autoantibodies with a novel microbead-based immunoassay.
Grossmann K; Roggenbuck D; Schröder C; Conrad K; Schierack P; Sack U
Cytometry A; 2011 Feb; 79(2):118-25. PubMed ID: 21265005
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies profile of rheumatoid arthritis patients during treatment with infliximab.
Elkayam O; Burke M; Vardinon N; Zakut V; Yitzhak RB; Paran D; Levartovsky D; Litinsky I; Caspi D
Autoimmunity; 2005 Mar; 38(2):155-60. PubMed ID: 16040336
[TBL] [Abstract][Full Text] [Related]
8. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
Muro Y; Sugiura K; Morita Y; Tomita Y
Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
Desplat-Jego S; Bardin N; Larida B; Sanmarco M
Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
[TBL] [Abstract][Full Text] [Related]
10. [Autoantibodies].
Ishihara Y
Rinsho Byori; 2005 Jun; 53(6):562-9. PubMed ID: 16026086
[TBL] [Abstract][Full Text] [Related]
11. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?
Bilici A; Yapici HS; Ercan S; Seker M; Ustaalioglu BB; Salman T; Orcun A; Gumus M
J BUON; 2012; 17(3):502-7. PubMed ID: 23033289
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of auto-antibodies in the serum of Omani patients with gastric cancer.
Al-Shukaili A; Al-Jabri AA; Al-Moundhri MS
Saudi Med J; 2006 Dec; 27(12):1873-7. PubMed ID: 17143367
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis.
Lazúrová I; Benhatchi K; Rovenský J; Kozáková D; Wagnerová H; Tajtáková M; Shoenfeld Y; Macejova Z
Ann N Y Acad Sci; 2009 Sep; 1173():211-6. PubMed ID: 19758153
[TBL] [Abstract][Full Text] [Related]
15. [Detection of anti-SSA/Ro antibody by ELISA, double immunodiffusion, and immunoblotting: a comparative study].
Tong SQ; Shi Q; Wen XH; Gan XD; Shi YP; Zhao Y; Zeng XF; Zhang FC; Dong Y
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2455-7. PubMed ID: 17156670
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
Faria AC; Barcellos KS; Andrade LE
J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of rheumatic manifestations and non-organ specific autoimmunity in patients with autoimmune thyreopathy].
Benhatchi K; Lazúrová I; Kozáková D; Rovenský J
Vnitr Lek; 2010 Feb; 56(2):106-10. PubMed ID: 20329579
[TBL] [Abstract][Full Text] [Related]
18. Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations.
Gulez N; Karaca NE; Aksu G; Kutukculer N
Autoimmunity; 2009 Jan; 42(1):74-9. PubMed ID: 19127458
[TBL] [Abstract][Full Text] [Related]
19. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
Homburger HA; Cahen YD; Griffiths J; Jacob GL
Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
[TBL] [Abstract][Full Text] [Related]
20. [Autoantibodies and peripheral arterial occlusive disease].
Kroeger K; Kreuzfelder E
Herz; 2004 Feb; 29(1):26-31. PubMed ID: 14968339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
